Algert Global LLC Cerus Corp Transaction History

Algert Global LLC

$4.77 Billion
Q2 2025

A detailed history of Algert Global LLC transactions in Cerus Corp stock. As of the latest transaction made, Algert Global LLC holds 92,436 shares of CERS stock, worth $134,032. This represents 0.0% of its overall portfolio holdings.

Number of Shares

92,436

Previous 92,436 -0.0%

Holding current value

$134,032

Previous $128,000 1.56%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 13, 2025	BUY	$1.39 - $2.15 $29,259 - $45,257	21,050 Added 29.49%	92,436 $128,000
Q4 2024 Feb 14, 2025	SELL	$1.52 - $2.03 $5,791 - $7,734	-3,810 Reduced 5.07%	71,386 $110,000
Q3 2024 Nov 12, 2024	BUY	$1.7 - $2.39 $34,187 - $48,062	20,110 Added 36.51%	75,196 $131,000
Q2 2024 Aug 14, 2024	BUY	$1.62 - $2.04 $89,239 - $112,375	55,086 New	55,086 $97,000
Q4 2023 Feb 14, 2024	SELL	$1.25 - $2.35 $588,902 - $1.11 Million	-471,122 Reduced 79.43%	121,970 $263,000
Q3 2023 Nov 13, 2023	BUY	$1.5 - $3.07 $106,530 - $218,031	71,020 Added 13.6%	593,092 $961,000
Q2 2023 Aug 14, 2023	SELL	$1.79 - $2.9 $255,722 - $414,299	-142,862 Reduced 21.49%	522,072 $1.28 Million
Q1 2023 May 12, 2023	BUY	$2.65 - $3.81 $1.36 Million - $1.96 Million	514,184 Added 341.08%	664,934 $1.98 Million
Q4 2022 Feb 13, 2023	SELL	$3.38 - $4.22 $382,075 - $477,028	-113,040 Reduced 42.85%	150,750 $550,000
Q3 2022 Nov 15, 2022	BUY	$3.43 - $5.83 $12,972 - $22,049	3,782 Added 1.45%	263,790 $950,000
Q2 2022 Aug 15, 2022	BUY	$4.41 - $5.69 $22,050 - $28,450	5,000 Added 1.96%	260,008 $1.38 Million
Q1 2022 May 16, 2022	BUY	$4.81 - $6.99 $979,594 - $1.42 Million	203,658 Added 396.61%	255,008 $1.4 Million
Q4 2021 Feb 14, 2022	BUY	$5.97 - $7.93 $306,559 - $407,205	51,350 New	51,350 $350,000

Others Institutions Holding CERS

# of Institutions

162

Shares Held

139M

Call Options Held

100K

Put Options Held

16K

View Full List

About CERUS CORP

Ticker CERS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 177,090,000
Market Cap $257M
Description
Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...

More about CERS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Algert Global LLC, based on Form 13F filings with the SEC.

News

Stay updated on Algert Global LLC with notifications on news.

Account

Algert Global LLC Cerus Corp Transaction History